SciELO - Scientific Electronic Library Online

 
vol.62 número9William Cheselden (1688-1752) y Gerard van der Gucht (1695-1776): La técnica quirúrgica, el arte de la estampa y la controversia en el libro urológico del siglo XVIII índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Archivos Españoles de Urología (Ed. impresa)

versión impresa ISSN 0004-0614

Resumen

PRAPOTNICH, Dominique et al. Intermittent androgen deprivation (IAD) for advance prostate cancer: Why not the standard of therapy?. Arch. Esp. Urol. [online]. 2009, vol.62, n.9, pp.689-694. ISSN 0004-0614.

Objectives: To review the literature and present a contemporary image of androgen deprivation for prostate cancer. Methods: We conducted a PubMed search on intermittent androgen deprivation. Articles obtained on intermittent androgen deprivation (IAD) and the experiences at Institut Montsouris were used for the review. Results: IAD is an approach to hormonal deprivation that holds effective cancer control while preventing the morbidity associated with continuous androgen blockade. IAD nuances have been assessed by urological community teams in order to verify its possible potential benefits. Evidence based approach supports the idea of IAD as a standard of therapy for advanced prostate cancer requiring hormone deprivation. Variation among medical teams' criteria for the treatment and surveillance await standardization. Conclusions: Reassessing the gold standard of hormonal blockade in advanced prostate cancer is mandatory. The undeniable evolution of IAD needs to be embraced by the urological community.

Palabras clave : Intermittent hormone treatment; Prostate cancer; Androgen blockade; Castration; Androgen antagonists.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons